Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

For very narrow results

When looking for a specific result

Best used for discovery & interchangable words

Recommended to be used in conjunction with other fields

Dates

to

Document Data
Library
People
Clear All
Clear All

For additional assistance using the Custom Query please check out our Help Page

i

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-ncov/index.html

Interim guidelines for biosafety and COVID-19 : interim laboratory biosafety guidelines for handling and processing specimens associated with coronavirus disease 2019 (COVID-19)

Filetype[PDF-108.58 KB]


English

Details:

  • Corporate Authors:
  • Description:
    Updated Sept. 19, 2020

    Summary of Recent Changes

    Revisions made on September 19, 2020 include:

    • New link under Resources to DLS Preparing and Supporting Laboratories Responding to COVID-19 page

    Revisions made on August 7, 2020 include:

    • Standard Precautions

    Revisions made on July 16, 2020 include:

    • Added DOT resources to Specimen Packing and Shipping and Resource section

    Revisions made on July 13, 2020 to update:

    • Language for virus isolation

    Revisions made on June 3, 2020 include:

    • Added anatomic pathology guidance for COVID-19

    • Updated Point-of-Care testing guidance for COVID-19

    Revisions made on May 11, 2020 include recommendations for:

    • Point-of-Care testing guidance for COVID-19

    Until more information becomes available, precautions should be taken in handling specimens that are suspected or confirmed for SARS-CoV-2. Timely communication between clinical and laboratory staff is essential to minimize the risk incurred in handling specimens from patients with possible SARS-CoV-2 infection. Such specimens should be labeled accordingly, and the laboratory should be alerted to ensure proper specimen handling. General and specific biosafety guidelines for handling SARS-CoV-2 specimens are provided below. For additional information on handling SARS-CoV-2 specimens, refer to the Laboratory Biosafety Frequently Asked Questions.

  • Content Notes:
    General Guidance -- Routine Viral Testing -- Anatomic Pathology -- Decentralized and Point of Care Testing -- Procedures with a High Likelihood to Generate Droplets or Aerosols -- Environmental Specimen Testing -- Virus Isolation -- Decontamination -- Laboratory Waste Management -- Specimen Packing and Shipping -- Resources.
  • Subjects:
  • Series:
  • Document Type:
  • Genre:
  • Collection(s):
  • Main Document Checksum:
  • Download URL:
  • File Type:

You May Also Like

Checkout today's featured content at stacks.cdc.gov